Individualized Renal Anaemia Care Important

Individualized Renal Anaemia Care Important –  In the contemporary era of erythropoiesis-stimulating agents (ESAs) and new anaemia treatments, measuring health-related quality of life (HRQoL) and a focus on the individual patient remain important, Fredric O. Finkelstein, MD, and Susan H. Finkelstein, MSW, of Yale University in New Haven, Connecticut, discussed in a recent review published in Advances in Chronic Kidney Disease.

Read the full article from Renal and Urology news here

 

Meet the Committee at the Anaemia Community